Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2023 | 3 |
2024 | 3 |
Search Results
6 results
Results by year
Filters applied: . Clear all
Page 1
Phase Ib study of anti-EGFR antibody (SCT200) in combination with anti-PD-1 antibody (SCT-I10A) for patients with RAS/BRAF wild-type metastatic colorectal cancer.
Cancer Biol Med. 2023 Dec 23:j.issn.2095-3941.2023.0301. doi: 10.20892/j.issn.2095-3941.2023.0301. Online ahead of print.
Cancer Biol Med. 2023.
PMID: 38148327
Combined score based on plasma fibrinogen and platelet-lymphocyte ratio as a prognostic biomarker in esophageal squamous cell carcinoma.
Yang Y, Tan H, Lu Y, Mei J, Zhang M, Bai M, Wang X, Ge S, Ning T, Zhang L, Ji Z, Duan J, Sun Y, Wang F, Liu R, Li H, Deng T.
Yang Y, et al.
BMC Cancer. 2024 Feb 22;24(1):249. doi: 10.1186/s12885-024-11968-6.
BMC Cancer. 2024.
PMID: 38389042
Free PMC article.
Item in Clipboard
[The efficacy of chemotherapy re-challenge in third-line setting for metastatic colorectal cancer patients: a real-world study].
Duan JJ, Ning T, Bai M, Zhang L, Li HL, Liu R, Ge SH, Wang X, Yang YC, Ji Z, Wang FX, Sun YS, Ba Y, Deng T.
Duan JJ, et al.
Zhonghua Zhong Liu Za Zhi. 2023 Nov 23;45(11):967-972. doi: 10.3760/cma.j.cn112152-20220901-00591.
Zhonghua Zhong Liu Za Zhi. 2023.
PMID: 37968083
Chinese.
Item in Clipboard
Chemotherapy re-use versus anti-angiogenic monotherapy as the third-line treatment of patients with metastatic colorectal cancer: a real-world cohort study.
Duan J, Zhu L, Shi Y, Wang W, Wang T, Ning T, Zhang L, Bai M, Li H, Liu R, Ge S, Wang X, Yang Y, Ji Z, Wang F, Sun Y, Ba Y, Deng T.
Duan J, et al.
BMC Cancer. 2024 Mar 5;24(1):302. doi: 10.1186/s12885-024-12072-5.
BMC Cancer. 2024.
PMID: 38443891
Free PMC article.
Item in Clipboard
The optimal time of starting adjuvant chemotherapy after curative surgery in patients with colorectal cancer.
Yang Y, Lu Y, Tan H, Bai M, Wang X, Ge S, Ning T, Zhang L, Duan J, Sun Y, Liu R, Li H, Ba Y, Deng T.
Yang Y, et al.
BMC Cancer. 2023 May 9;23(1):422. doi: 10.1186/s12885-023-10863-w.
BMC Cancer. 2023.
PMID: 37161562
Free PMC article.
Item in Clipboard
Combinational zimberelimab plus lenvatinib and chemotherapy for alpha-fetoprotein elevated, advanced gastric cancer patients (AFPGC): a phase 1 dose-escalation study.
Deng T, Wang F, Zhang L, Ning T, Sun Y, Ge S, Bai M, Lu Y, Li H, Ba Y.
Deng T, et al.
Cancer Immunol Immunother. 2024 Jun 4;73(8):154. doi: 10.1007/s00262-024-03743-0.
Cancer Immunol Immunother. 2024.
PMID: 38833154
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite